CCL is now running the Oncimmune EarlyCDT Lung test. The EarlyCDT Lung test is a simple finger prick blood test which results can indicate whether an individual has an increased risk of lung cancer.
Read More
This Bowel Cancer Awareness month, Cambridge Clinical Laboratories is announcing that it is opening up the availability of the FIT test (Faecal Immunochemical Test) to all.
Read More
Cambridge Clinical Laboratories reflects on our work this World Health Day 2022.
Read More
Cambridge Clinical Laboratories CEO Dr Anthony Cooke has been announced as Chair of the Scientific Advisory Board for The Laboratory and Testing Industry Organisation.
Read More
Cambridge Clinical Laboratories launches our new suite of tests to support the UK prostate cancer pathway.
Read More
Cambridge Clinical Laboratories (CCL) announces today, Friday 27 August, that CCL will be the UK partner for Prostatype Genomics in bringing the Prostatype® prostate cancer gene test to the UK market.
Read More
Back in November 2020 we spoke with our CEO Dr Tony Cooke about how CCL had responded to the Covid-19 pandemic. Nine months on, how are things looking for this leading UK diagnostics lab?
Read More
A research study that Cambridge Clinical Laboratories contributed to has been published by Nature Journal, with both CEO Dr Tony Cooke, and Clinical Laboratory Manager, Mike Morel being cited.
Read More
Cambridge Clinical Laboratories has launched a new partnership with C-19 Direct to provide direct to consumer Covid-19 travel testing.
Read More
A focus on Prostate Cancer - what it is, a snapshot of Prostate Cancer in the UK, and a summary of the tests available at Cambridge Clinical Laboratories.
Read More
Cambridge Clinical Laboratories (CCL) is delighted to have successfully added its SARS-CoV-2 service (using the Primerdesign Ltd Genesig Assay) to its UKAS accreditation – ISO 15189 - the international Quality standard for medical laboratory testing.
Read More
It’s been a year of huge demand for Cambridge Clinical Laboratories and not the year our CEO, Dr Tony Cooke, had planned. In 2020 CCL’s team has doubled, they are processing the equivalent of four months (pre pandemic) testing every week, and Tony has been at the forefront in enabling private labs to support with Coronavirus testing.
Here we reflect on the past nine months.
Read More
CCL CEO Dr Tony Cooke has been supporting the Covid-19 Volunteer Testing Network.
Read More